Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Molecular Diagnostics, Hematology), Application (Clinical Pathology, Bacteriology, Virology), Animal, End User (Diagnostics Labs, Clinics) - Global Forecast to 2027
The companion animal diagnostics market is projected to reach USD 3.8 Billion by 2027 from USD 2.4 Billion in 2022 at a CAGR of 9.6% during the forecast period. The growth in this market is mainly attributed to the increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
“Clinical Biochemistry segment holds largest share in the companion animal diagnostics market in 2021”
The companion animal diagnostics market is segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and other companion animal diagnostic technologies on the basis of technologies. The clinical biochemistry segment holds the largest share of the companion animal diagnostics market in 2021. Clinical biochemistry is an important technology used for screening infectious and metabolic disorders in small animals. The clinical biochemistry market is segmented into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis.
“Clinical Pathology segment is expected to grow at the fastest growth rate during 2022-2027”
The companion animal diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications based on application type. In 2021, clinical pathology was the largest application segment in this market owing to the high volume of clinical pathology tests performed on companion animals. Clinical pathology encompasses hematology, clinical chemistry, cytopathology, endocrinology, urinalysis, coagulation, immunohematology, and general pathology. In the case of chronic diseases, veterinarians recommend routine blood and urine check-ups, wherein pathologists work alongside vets in order to evaluate the true causes of diseases.
“The diagnostics laboratories holds the largest share of companion animal diagnostics market in 2021”
The companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals & clinics, research institutes & universities,and home care settings based on the end user type. The diagnostic laboratories segment holds the largest share of of this market in 2021. The large share of this segment can be attributed to a large number of samples received for analysis in these laboratories from small and large animal practices. Rising awareness among pet owners regarding routine and preventive care is further expected to propel market growth.
“North America accounted for the largest share of the companion animal diagnostics market in 2021”
The companion animal diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa based on the region type. North America holds largest share of of the companion animal diagnostics market in 2021. The large share of this segment can be attributed to the increasing animal population, growing pet insurance, and rising animal health expenditure in North America. The Asia Pacific region is projected to grow at a CAGR of during the forecast period. Factors such as the rapidly increasing animal population, growing awareness about animal welfare, and the rising prevalence of zoonotic diseases are driving the growth of this regional market.
A breakdown of the primary participants (supply-side) for the companion animal diagnostics market referred to for this report is provided below:
Research Coverage:
The market study covers the companion animal diagnostics market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by Technology, Application, Animal, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the companion animal diagnostics market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
“Clinical Biochemistry segment holds largest share in the companion animal diagnostics market in 2021”
The companion animal diagnostics market is segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and other companion animal diagnostic technologies on the basis of technologies. The clinical biochemistry segment holds the largest share of the companion animal diagnostics market in 2021. Clinical biochemistry is an important technology used for screening infectious and metabolic disorders in small animals. The clinical biochemistry market is segmented into clinical chemistry analysis, glucose monitoring, and blood gas electrolyte analysis.
“Clinical Pathology segment is expected to grow at the fastest growth rate during 2022-2027”
The companion animal diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications based on application type. In 2021, clinical pathology was the largest application segment in this market owing to the high volume of clinical pathology tests performed on companion animals. Clinical pathology encompasses hematology, clinical chemistry, cytopathology, endocrinology, urinalysis, coagulation, immunohematology, and general pathology. In the case of chronic diseases, veterinarians recommend routine blood and urine check-ups, wherein pathologists work alongside vets in order to evaluate the true causes of diseases.
“The diagnostics laboratories holds the largest share of companion animal diagnostics market in 2021”
The companion animal diagnostics market is segmented into diagnostic laboratories, veterinary hospitals & clinics, research institutes & universities,and home care settings based on the end user type. The diagnostic laboratories segment holds the largest share of of this market in 2021. The large share of this segment can be attributed to a large number of samples received for analysis in these laboratories from small and large animal practices. Rising awareness among pet owners regarding routine and preventive care is further expected to propel market growth.
“North America accounted for the largest share of the companion animal diagnostics market in 2021”
The companion animal diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa based on the region type. North America holds largest share of of the companion animal diagnostics market in 2021. The large share of this segment can be attributed to the increasing animal population, growing pet insurance, and rising animal health expenditure in North America. The Asia Pacific region is projected to grow at a CAGR of during the forecast period. Factors such as the rapidly increasing animal population, growing awareness about animal welfare, and the rising prevalence of zoonotic diseases are driving the growth of this regional market.
A breakdown of the primary participants (supply-side) for the companion animal diagnostics market referred to for this report is provided below:
- By Company Type: Tier 1–60%, Tier 2–30%, and Tier 3–10%
- By Designation: C-level–30%, Director Level–50%, and Others–20%
- By Region: North America–45%, Europe–15%, Asia Pacific–23%, Latin America- 10%, and Middle East and Africa– 5%
Research Coverage:
The market study covers the companion animal diagnostics market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by Technology, Application, Animal, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the companion animal diagnostics market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED – BY TYPE
1.3.2 MARKETS COVERED – BY REGION
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 7 SUPPLY SIDE ANALYSIS OF TOP COMPANIES (2021)
FIGURE 8 CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF COMPANION ANIMAL DIAGNOSTICS MARKET (2022–2027)
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 10 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: COMPANION ANIMAL DIAGNOSTICS MARKET
3 EXECUTIVE SUMMARY
FIGURE 11 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 12 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET
4 PREMIUM INSIGHTS
4.1 COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW
FIGURE 16 GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH
4.2 REGIONAL MIX: COMPANION ANIMAL DIAGNOSTICS MARKET
FIGURE 17 ASIA PACIFIC TO REGISTER CAGR OF 10.1% DURING FORECAST PERIOD
4.3 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY AND COUNTRY (2021)
FIGURE 18 CHINA TO HOLD LARGEST SHARE OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET IN 2021
4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 AUSTRALIA AND MEXICO TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
4.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 COMPANION ANIMAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing companion animal population
TABLE 3 PET POPULATION, BY ANIMAL, 2014–2020 (MILLION)
5.2.1.2 Rising demand for pet insurance and growing animal health expenditure
TABLE 4 AVERAGE PREMIUMS PAID IN US, 2019 VS. 2020
FIGURE 22 US: PET INDUSTRY EXPENDITURE, 2010–2020
TABLE 5 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2016) (USD MILLION)
5.2.1.3 Growing number of veterinary practitioners and their rising income levels in developed countries
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
5.2.2 RESTRAINTS
5.2.2.1 Rising pet care costs
5.2.3 OPPORTUNITIES
5.2.3.1 Increased use of PCR testing panels to rule out COVID-19 virus in animals
5.2.3.2 Growing demand for rapid tests and portable instruments for point-of-care diagnostic services
5.2.3.3 Use of advanced technologies to improve disease diagnosis accuracy in companion animals
5.2.4 CHALLENGES
5.2.4.1 Shortage of veterinary practitioners in developing countries
TABLE 7 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
5.3 INDUSTRY TRENDS
5.3.1 ADOPTION OF MULTIPLE TESTING PANELS
TABLE 8 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS
5.3.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
5.3.3 GROWING CONSOLIDATION IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY
TABLE 9 MAJOR ACQUISITIONS IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY
5.4 DISEASE TRENDS
5.4.1 ZOONOTIC DISEASES
TABLE 10 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS GLOBALLY
5.4.2 OBESITY AND DIABETES
5.5 TECHNOLOGICAL ANALYSIS
5.5.1 KEY TECHNOLOGY
5.5.1.1 Development of portable instruments for POC diagnostic services
TABLE 11 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
5.5.2 ADJACENT TECHNOLOGY
5.5.2.1 Development of rapid and sensitive veterinary diagnostic kits
5.6 PRICING ANALYSIS
TABLE 12 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2019 (USD)
5.7 IMPACT OF COVID-19 ON COMPANION ANIMAL DIAGNOSTICS MARKET
TABLE 13 GLOBAL SNAPSHOT OF REPORTED CASES OF NATURALLY ACQUIRED SARS-COV-2 (COVID-19) INFECTIONS IN ANIMALS
FIGURE 23 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN COMPANION ANIMAL DIAGNOSTICS MARKET
FIGURE 24 YC–YCC SHIFT IN COMPANION ANIMAL DIAGNOSTICS MARKET
5.9 VALUE CHAIN ANALYSIS
FIGURE 25 COMPANION ANIMAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
5.10 ECOSYSTEM MARKET MAP
FIGURE 26 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS
FIGURE 27 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF SUPPLIERS
5.11.4 BARGAINING POWER OF BUYERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 SUPPLY CHAIN ANALYSIS
FIGURE 28 COMPANION ANIMAL DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
5.13 REGULATORY ANALYSIS
5.13.1 US
5.13.2 EUROPE
5.14 PATENT ANALYSIS
5.14.1 PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTICS
FIGURE 29 PATENT PUBLICATION TRENDS (2011–APRIL 2022)
5.14.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL DIAGNOSTICS DIAGNOSTIC PATENTS (JANUARY 2011–APRIL 2022)
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR COMPANION ANIMAL DIAGNOSTICS PATENTS (JANUARY 2011–APRIL 2022)
5.15 KEY CONFERENCES & EVENTS DURING 2021-2023
TABLE 15 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
5.16.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 17 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
TABLE 18 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
6.1.1 IMPACT OF COVID-19 ON TECHNOLOGY TYPE
6.2 CLINICAL BIOCHEMISTRY
TABLE 19 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN MARKET
TABLE 20 CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 CLINICAL CHEMISTRY ANALYSIS
TABLE 22 KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE IN MARKET
TABLE 23 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 24 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.1 Reagents, clips, and cartridges
6.2.1.1.1 Increasing pet healthcare expenditure and rising number of screening tests performed to drive market growth
TABLE 25 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2 Analyzers
6.2.1.2.1 Increasing installations of clinical chemistry analyzers to drive market growth
TABLE 26 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 GLUCOSE MONITORING
TABLE 27 KEY GLUCOSE MONITORING PRODUCTS AVAILABLE IN MARKET
TABLE 28 GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 29 GLUCOSE MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.1 Blood glucose strips
6.2.2.1.1 Blood glucose strips to account for largest share of market in 2021
TABLE 30 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2 Glucose monitors
6.2.2.2.1 Use of glucose monitors to help in diagnostic and therapeutic decisions
TABLE 31 GLUCOSE MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.3 Urine glucose strips
6.2.2.3.1 Urine glucose strips to measure glucose and ketone concentration in urine
TABLE 32 LIST OF KEY URINE GLUCOSE STRIPS AVAILABLE IN MARKET
TABLE 33 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 BLOOD GAS ELECTROLYTE ANALYSIS
TABLE 34 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 35 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.1 Reagents, clips, and cartridges
6.2.3.1.1 Easy availability of animal species-specific preloaded reagent clips to support market growth
TABLE 36 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.2 Blood gas & electrolyte analyzers
6.2.3.2.1 Blood gas and electrolyte analyzers to determine oxygen and carbon dioxide amounts in blood
TABLE 37 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 IMMUNODIAGNOSTICS
TABLE 38 LIST OF KEY COMPANION ANIMAL IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN MARKET
TABLE 39 IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 40 IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1 LATERAL FLOW ASSAYS
TABLE 41 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 42 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1.1 Rapid tests
6.3.1.1.1 Rising prevalence of infectious diseases to drive lateral flow rapid tests adoption
TABLE 43 LATERAL FLOW KITS: ADVANTAGES & DISADVANTAGES
TABLE 44 KEY PLAYERS OFFERING LATERAL TEST KITS
TABLE 45 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1.2 Strip readers (Lateral flow readers)
6.3.1.2.1 Lateral flow readers to be adopted in in-house testing centers
TABLE 46 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 ELISA TESTS
6.3.2.1 Elisa kits to be adopted for viral disease testing in companion animals
TABLE 47 ELISA: ADVANTAGES & DISADVANTAGES
TABLE 48 KEY PLAYERS OFFERING ELISA KITS
TABLE 49 ELISA TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
6.3.3.1 Growing number of allergy cases in pets to drive market growth
TABLE 50 ALLERGEN-SPECIFIC IMMUNODIAGNOSTICS TEST KITS AVAILABLE
TABLE 51 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.4 IMMUNOASSAY ANALYZERS
6.3.4.1 Large number of samples can be loaded into immunoassay analyzers to determine immunoassay tests results
TABLE 52 KEY PLAYERS OFFERING IMMUNOASSAY ANALYZERS
TABLE 53 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.5 OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 54 KEY PLAYERS OFFERING IMMUNOASSAY REAGENTS & CONSUMABLES
TABLE 55 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 HEMATOLOGY
TABLE 56 KEY HEMATOLOGY PRODUCTS AVAILABLE
TABLE 57 HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 58 HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.1 CARTRIDGES
6.4.1.1 Hematology cartridges to measure hematocrit and hemoglobin levels in animal blood samples
TABLE 59 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.2 ANALYZERS
6.4.2.1 Hematology analyzers to measure blood cell count and coagulation time of blood
TABLE 60 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 URINALYSIS
TABLE 61 LIST OF KEY URINALYSIS PRODUCTS AVAILABLE
TABLE 62 URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 63 URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5.1 CLIPS & CARTRIDGES/PANELS
6.5.1.1 Clips and cartridges/panels to measure multiple electrolytes and metabolites kidney diseases and urinary tract infections detection
TABLE 64 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5.2 URINE ANALYZERS
6.5.2.1 Technological advancements to support market growth
TABLE 65 URINE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5.3 URINE TEST STRIPS
6.5.3.1 Urine test strips to qualitatively evaluate urine parameters
TABLE 66 URINE TEST STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 MOLECULAR DIAGNOSTICS
TABLE 67 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 68 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6.1 POLYMERASE CHAIN REACTION TESTS
6.6.1.1 Increased laboratory usage of PCR in proteomics and genomics to support market growth
TABLE 69 LIST OF POLYMERASE CHAIN REACTION TESTS AVAILABLE
TABLE 70 PCR TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6.2 MICROARRAYS
6.6.2.1 Growing applications of biochips in infectious diseases identification to propel market growth
TABLE 71 LIST OF MICROARRAYS TESTS AVAILABLE
TABLE 72 MICROARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 73 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES
TABLE 74 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 75 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CLINICAL PATHOLOGY
7.2.1 INCREASING PET HEALTH SCREENING AND DISEASE DIAGNOSIS TO MAKE CLINICAL PATHOLOGY LARGEST APPLICATION SEGMENT
TABLE 76 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 BACTERIOLOGY
7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH
TABLE 77 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 VIROLOGY
7.4.1 RISING NUMBER OF VIRAL OUTBREAKS TO SUPPORT MARKET GROWTH
TABLE 78 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 PARASITOLOGY
7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT MARKET GROWTH
TABLE 79 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 80 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
TABLE 81 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
8.2 DOGS
8.2.1 RISING PET DOG POPULATION TO DRIVE MARKET GROWTH
TABLE 82 DOG POPULATION, BY COUNTRY, 2018–2020 (MILLION)
TABLE 83 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CATS
8.3.1 GROWING RESEARCH INTO FELINE HEALTHCARE AND WELLBEING TO SUPPORT MARKET GROWTH
TABLE 84 CAT POPULATION, BY COUNTRY, 2018-2020 (MILLION)
TABLE 85 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 HORSES
8.4.1 GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH
TABLE 86 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER COMPANION ANIMALS
TABLE 87 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)
9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 88 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 DIAGNOSTIC LABORATORIES TO RECEIVE LARGE SAMPLE VOLUME FOR DIAGNOSIS
TABLE 89 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 VETERINARY HOSPITALS & CLINICS
9.3.1 VETERINARY HOSPITALS & CLINICS TO BE FIRST POINTS OF CONTACT FOR PET OWNERS
TABLE 90 BASIC ANNUAL EXPENSES FOR CATS AND DOGS IN THE US IN
2021-2022 (USD)
TABLE 91 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 RESEARCH INSTITUTES & UNIVERSITIES
9.4.1 INCREASING INDUSTRY-ACADEMIA COLLABORATIONS TO PROPEL MARKET GROWTH
TABLE 92 COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 HOME-CARE SETTINGS
9.5.1 IMPROVED CARE AND COST CONTROL TO DRIVE POC DIAGNOSTICS ADOPTION IN HOME CARE SETTINGS
TABLE 93 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME-CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 94 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
TABLE 95 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 97 NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 102 NORTH AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 103 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 104 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 105 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 107 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 108 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate companion animal diagnostics market in
North America
TABLE 109 US: PRIVATE CLINICAL PRACTICES FOR COMPANION ANIMAL, 2016 VS. 2020
FIGURE 35 US: EXPENDITURE ON VET VISITS
TABLE 110 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 111 US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 112 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 113 US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 116 US: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 US: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 118 US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 119 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 120 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 121 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 122 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Awareness of pet health to propel market growth
TABLE 123 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 124 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 125 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 126 CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 128 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 129 CANADA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 130 CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 131 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 132 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 133 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 134 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 135 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
FIGURE 36 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
TABLE 136 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 137 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 138 EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 139 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 140 EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 143 EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 144 EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 145 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 146 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 147 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 148 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 149 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European companion animal diagnostics market
TABLE 150 GERMANY: PET POPULATION (CATS AND DOGS), 2017 VS. 2020 (MILLION)
TABLE 151 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 152 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 153 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 154 GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 156 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 157 GERMANY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 158 GERMANY: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 159 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 160 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 161 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 162 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 163 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Stable increase in pet ownership and preventive measures against animal diseases to drive market growth
TABLE 164 UK: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION)
TABLE 165 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 166 UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 167 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 168 UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 170 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 171 UK: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 172 UK: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 173 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 174 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 175 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 176 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 177 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Technological expertise and innovations to attract market players
TABLE 178 FRANCE: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION)
TABLE 179 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 180 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 181 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 182 FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 184 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 185 FRANCE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 186 FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 187 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 189 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 190 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 191 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increased pet adoption and better availability of pet products through large-scale outlets to support market growth
TABLE 192 ITALY: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION)
TABLE 193 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 194 ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 195 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 196 ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 198 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 199 ITALY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 200 ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 201 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 202 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 203 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 204 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 205 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising animal health expenditure and growing number of veterinary facilities to drive market growth
TABLE 206 SPAIN: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION)
TABLE 207 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 208 SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 209 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 210 SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 212 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 213 SPAIN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 214 SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 215 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 216 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 217 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 218 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 219 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 BENELUX
10.3.6.1 Increasing pet population in Benelux to drive market growth
TABLE 220 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 221 BENELUX: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 222 BENELUX: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 223 BENELUX: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 224 BENELUX: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 225 BENELUX: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 226 BENELUX: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 227 BENELUX: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 228 BENELUX: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 229 BENELUX: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 230 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 231 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 232 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 233 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 234 ROE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 235 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 236 ROE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 ROE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 238 ROE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 239 ROE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 240 ROE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 241 ROE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 242 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 243 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 244 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 245 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 37 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
TABLE 246 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 247 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 248 ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 249 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 250 ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 251 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 252 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 253 ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 254 ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 255 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 256 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 257 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 258 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 259 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to dominate Asia Pacific companion animal diagnostics market
TABLE 260 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 261 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 262 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 263 CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 264 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 265 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 266 CHINA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 267 CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 268 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 269 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 270 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 271 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 272 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising demand for imported pet breeds to drive market growth
TABLE 273 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 274 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 275 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 276 JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 278 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 279 JAPAN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 280 JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 281 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 282 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 283 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 284 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 285 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Untapped market with large growth potential in companion animal diagnostics to support segment growth
TABLE 286 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 287 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 288 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 289 INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 291 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 292 INDIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 293 INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 294 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 295 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 296 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 297 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 298 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Rising pet insurance and pet health expenditure to drive market growth
TABLE 299 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 300 AUSTRALIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 301 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 302 AUSTRALIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 303 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 304 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 305 AUSTRALIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 306 AUSTRALIA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 307 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 308 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 309 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 310 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 311 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 312 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 313 REST OF ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 314 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 315 REST OF ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 316 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 317 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 318 REST OF ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 319 REST OF ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 325 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 326 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 327 LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 328 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 329 LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 330 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 331 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 332 LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 333 LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 334 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 335 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 336 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 337 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 338 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil to possess third-largest pet population globally
TABLE 339 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 340 BRAZIL: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 341 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 342 BRAZIL: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 343 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 344 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 345 BRAZIL: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 346 BRAZIL: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 347 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 348 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 349 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 350 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 351 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Mexico to hold second-highest position in Latin American pet care market
TABLE 352 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 353 MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 354 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 355 MEXICO: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 356 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 357 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 358 MEXICO: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 359 MEXICO: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 360 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 361 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 362 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 363 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 364 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 365 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 366 REST OF LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 367 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 368 REST OF LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 369 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 370 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 371 REST OF LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 372 REST OF LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 373 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 374 REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 375 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 376 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 377 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST
10.6.1 RELUCTANCE TO SPEND ON PET HEALTH TO HINDER MARKET GROWTH
TABLE 378 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 379 MIDDLE EAST: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 380 MIDDLE EAST: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 381 MIDDLE EAST: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 382 MIDDLE EAST: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 383 MIDDLE EAST: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 384 MIDDLE EAST: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 385 MIDDLE EAST: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 386 MIDDLE EAST: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 387 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 388 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 389 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 390 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.7 AFRICA
10.7.1 DISEASES IN IMPORTED BREEDS TO DRIVE MARKET GROWTH
TABLE 391 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 392 AFRICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 393 AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 394 AFRICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 395 AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 396 AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 397 AFRICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 398 AFRICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 399 AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 400 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 401 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 402 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 403 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 38 REVENUE ANALYSIS OF TOP PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 39 COMPANION ANIMAL DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 40 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT (2021)
11.6 COMPANY EVALUATION QUADRANT FOR STARTUPS
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 STARTING BLOCKS
11.6.4 RESPONSIVE COMPANIES
FIGURE 41 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS (2021)
11.7 COMPANY PRODUCT FOOTPRINT
TABLE 404 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS
TABLE 405 ANIMAL TYPE FOOTPRINT OF MAJOR PLAYERS
TABLE 406 END USER FOOTPRINT OF MAJOR PLAYERS
TABLE 407 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS
11.8 COMPETITIVE SCENARIO
11.8.1 DEALS
TABLE 408 KEY DEALS, JANUARY 2019 TO MARCH 2022
11.8.2 PRODUCT LAUNCHES
11.8.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 IDEXX LABORATORIES, INC.
TABLE 409 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
12.1.2 ZOETIS INC.
TABLE 410 ZOETIS, INC.: BUSINESS OVERVIEW
FIGURE 43 ZOETIS, INC.: COMPANY SNAPSHOT
12.1.3 HESKA CORPORATION
TABLE 411 HESKA CORPORATION: BUSINESS OVERVIEW
FIGURE 44 HESKA CORPORATION: COMPANY SNAPSHOT
12.1.4 THERMO FISHER SCIENTIFIC INC.
TABLE 412 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
12.1.5 BIOM?RIEUX SA
TABLE 413 BIOM?RIEUX SA: BUSINESS OVERVIEW
FIGURE 46 BIOM?RIEUX SA: COMPANY SNAPSHOT
12.1.6 VIRBAC
TABLE 414 VIRBAC: BUSINESS OVERVIEW
FIGURE 47 VIRBAC: COMPANY SNAPSHOT
12.1.7 NEOGEN CORPORATION
TABLE 415 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 48 NEOGEN CORPORATION: COMPANY SNAPSHOT
12.1.8 FUJIFILM HOLDINGS CORPORATION
TABLE 416 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 49 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
12.1.9 INDICAL BIOSCIENCE GMBH
TABLE 417 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW
12.1.10 IDVET
TABLE 418 IDVET: BUSINESS OVERVIEW
12.1.11 RANDOX LABORATORIES, LTD.
TABLE 419 RANDOX LABORATORIES, LTD.: BUSINESS OVERVIEW
12.1.12 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
TABLE 420 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.:
BUSINESS OVERVIEW
12.1.13 BIONOTE, INC.
TABLE 421 BIONOTE, INC.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 SKYLA CORPORATION
TABLE 422 SKYLA CORPORATION: BUSINESS OVERVIEW
12.2.2 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
TABLE 423 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.: BUSINESS OVERVIEW
12.2.3 URIT MEDICAL ELECTRONIC CO., LTD.
TABLE 424 URIT MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
12.2.4 EUROLYSER DIAGNOSTICA GMBH
TABLE 425 EUROLYSER DIAGNOSTICA GMBH: BUSINESS OVERVIEW
12.2.5 NOVA BIOMEDICAL
TABLE 426 NOVA BIOMEDICAL: BUSINESS OVERVIEW
12.2.6 FASSISI GMBH
TABLE 427 FASSISI GMBH: BUSINESS OVERVIEW
12.2.7 SWISSAVANS AG
TABLE 428 SWISSAVANS AG: BUSINESS OVERVIEW
12.2.8 ALVEDIA
TABLE 429 ALVEDIA: BUSINESS OVERVIEW
12.2.9 MEGACOR VETERINARY DIAGNOSTICS
TABLE 430 MEGACOR VETERINARY DIAGNOSTICS: BUSINESS OVERVIEW
12.2.10 BIOPANDA REAGENTS LTD
TABLE 431 BIOPANDA REAGENTS LTD: BUSINESS OVERVIEW
12.2.11 ANIPOC LTD
TABLE 432 ANIPOC LTD: BUSINESS OVERVIEW
12.2.12 RING BIOTECHNOLOGY CO LTD.
TABLE 433 RING BIOTECHNOLOGY CO LTD.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED – BY TYPE
1.3.2 MARKETS COVERED – BY REGION
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 7 SUPPLY SIDE ANALYSIS OF TOP COMPANIES (2021)
FIGURE 8 CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF COMPANION ANIMAL DIAGNOSTICS MARKET (2022–2027)
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 10 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: COMPANION ANIMAL DIAGNOSTICS MARKET
3 EXECUTIVE SUMMARY
FIGURE 11 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 12 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 13 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET
4 PREMIUM INSIGHTS
4.1 COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW
FIGURE 16 GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH
4.2 REGIONAL MIX: COMPANION ANIMAL DIAGNOSTICS MARKET
FIGURE 17 ASIA PACIFIC TO REGISTER CAGR OF 10.1% DURING FORECAST PERIOD
4.3 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY AND COUNTRY (2021)
FIGURE 18 CHINA TO HOLD LARGEST SHARE OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET IN 2021
4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 AUSTRALIA AND MEXICO TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
4.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 COMPANION ANIMAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing companion animal population
TABLE 3 PET POPULATION, BY ANIMAL, 2014–2020 (MILLION)
5.2.1.2 Rising demand for pet insurance and growing animal health expenditure
TABLE 4 AVERAGE PREMIUMS PAID IN US, 2019 VS. 2020
FIGURE 22 US: PET INDUSTRY EXPENDITURE, 2010–2020
TABLE 5 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2016) (USD MILLION)
5.2.1.3 Growing number of veterinary practitioners and their rising income levels in developed countries
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
5.2.2 RESTRAINTS
5.2.2.1 Rising pet care costs
5.2.3 OPPORTUNITIES
5.2.3.1 Increased use of PCR testing panels to rule out COVID-19 virus in animals
5.2.3.2 Growing demand for rapid tests and portable instruments for point-of-care diagnostic services
5.2.3.3 Use of advanced technologies to improve disease diagnosis accuracy in companion animals
5.2.4 CHALLENGES
5.2.4.1 Shortage of veterinary practitioners in developing countries
TABLE 7 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
5.3 INDUSTRY TRENDS
5.3.1 ADOPTION OF MULTIPLE TESTING PANELS
TABLE 8 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS
5.3.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
5.3.3 GROWING CONSOLIDATION IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY
TABLE 9 MAJOR ACQUISITIONS IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY
5.4 DISEASE TRENDS
5.4.1 ZOONOTIC DISEASES
TABLE 10 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS GLOBALLY
5.4.2 OBESITY AND DIABETES
5.5 TECHNOLOGICAL ANALYSIS
5.5.1 KEY TECHNOLOGY
5.5.1.1 Development of portable instruments for POC diagnostic services
TABLE 11 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
5.5.2 ADJACENT TECHNOLOGY
5.5.2.1 Development of rapid and sensitive veterinary diagnostic kits
5.6 PRICING ANALYSIS
TABLE 12 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2019 (USD)
5.7 IMPACT OF COVID-19 ON COMPANION ANIMAL DIAGNOSTICS MARKET
TABLE 13 GLOBAL SNAPSHOT OF REPORTED CASES OF NATURALLY ACQUIRED SARS-COV-2 (COVID-19) INFECTIONS IN ANIMALS
FIGURE 23 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN COMPANION ANIMAL DIAGNOSTICS MARKET
FIGURE 24 YC–YCC SHIFT IN COMPANION ANIMAL DIAGNOSTICS MARKET
5.9 VALUE CHAIN ANALYSIS
FIGURE 25 COMPANION ANIMAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
5.10 ECOSYSTEM MARKET MAP
FIGURE 26 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS
FIGURE 27 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 14 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF SUPPLIERS
5.11.4 BARGAINING POWER OF BUYERS
5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 SUPPLY CHAIN ANALYSIS
FIGURE 28 COMPANION ANIMAL DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
5.13 REGULATORY ANALYSIS
5.13.1 US
5.13.2 EUROPE
5.14 PATENT ANALYSIS
5.14.1 PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTICS
FIGURE 29 PATENT PUBLICATION TRENDS (2011–APRIL 2022)
5.14.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL DIAGNOSTICS DIAGNOSTIC PATENTS (JANUARY 2011–APRIL 2022)
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR COMPANION ANIMAL DIAGNOSTICS PATENTS (JANUARY 2011–APRIL 2022)
5.15 KEY CONFERENCES & EVENTS DURING 2021-2023
TABLE 15 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
5.16.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 17 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
TABLE 18 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
6.1.1 IMPACT OF COVID-19 ON TECHNOLOGY TYPE
6.2 CLINICAL BIOCHEMISTRY
TABLE 19 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN MARKET
TABLE 20 CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 CLINICAL CHEMISTRY ANALYSIS
TABLE 22 KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE IN MARKET
TABLE 23 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 24 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.1 Reagents, clips, and cartridges
6.2.1.1.1 Increasing pet healthcare expenditure and rising number of screening tests performed to drive market growth
TABLE 25 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2 Analyzers
6.2.1.2.1 Increasing installations of clinical chemistry analyzers to drive market growth
TABLE 26 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 GLUCOSE MONITORING
TABLE 27 KEY GLUCOSE MONITORING PRODUCTS AVAILABLE IN MARKET
TABLE 28 GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 29 GLUCOSE MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.1 Blood glucose strips
6.2.2.1.1 Blood glucose strips to account for largest share of market in 2021
TABLE 30 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2 Glucose monitors
6.2.2.2.1 Use of glucose monitors to help in diagnostic and therapeutic decisions
TABLE 31 GLUCOSE MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.3 Urine glucose strips
6.2.2.3.1 Urine glucose strips to measure glucose and ketone concentration in urine
TABLE 32 LIST OF KEY URINE GLUCOSE STRIPS AVAILABLE IN MARKET
TABLE 33 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 BLOOD GAS ELECTROLYTE ANALYSIS
TABLE 34 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 35 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.1 Reagents, clips, and cartridges
6.2.3.1.1 Easy availability of animal species-specific preloaded reagent clips to support market growth
TABLE 36 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.2 Blood gas & electrolyte analyzers
6.2.3.2.1 Blood gas and electrolyte analyzers to determine oxygen and carbon dioxide amounts in blood
TABLE 37 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 IMMUNODIAGNOSTICS
TABLE 38 LIST OF KEY COMPANION ANIMAL IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN MARKET
TABLE 39 IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 40 IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1 LATERAL FLOW ASSAYS
TABLE 41 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 42 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1.1 Rapid tests
6.3.1.1.1 Rising prevalence of infectious diseases to drive lateral flow rapid tests adoption
TABLE 43 LATERAL FLOW KITS: ADVANTAGES & DISADVANTAGES
TABLE 44 KEY PLAYERS OFFERING LATERAL TEST KITS
TABLE 45 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1.2 Strip readers (Lateral flow readers)
6.3.1.2.1 Lateral flow readers to be adopted in in-house testing centers
TABLE 46 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 ELISA TESTS
6.3.2.1 Elisa kits to be adopted for viral disease testing in companion animals
TABLE 47 ELISA: ADVANTAGES & DISADVANTAGES
TABLE 48 KEY PLAYERS OFFERING ELISA KITS
TABLE 49 ELISA TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
6.3.3.1 Growing number of allergy cases in pets to drive market growth
TABLE 50 ALLERGEN-SPECIFIC IMMUNODIAGNOSTICS TEST KITS AVAILABLE
TABLE 51 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.4 IMMUNOASSAY ANALYZERS
6.3.4.1 Large number of samples can be loaded into immunoassay analyzers to determine immunoassay tests results
TABLE 52 KEY PLAYERS OFFERING IMMUNOASSAY ANALYZERS
TABLE 53 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.5 OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 54 KEY PLAYERS OFFERING IMMUNOASSAY REAGENTS & CONSUMABLES
TABLE 55 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 HEMATOLOGY
TABLE 56 KEY HEMATOLOGY PRODUCTS AVAILABLE
TABLE 57 HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 58 HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.1 CARTRIDGES
6.4.1.1 Hematology cartridges to measure hematocrit and hemoglobin levels in animal blood samples
TABLE 59 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4.2 ANALYZERS
6.4.2.1 Hematology analyzers to measure blood cell count and coagulation time of blood
TABLE 60 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 URINALYSIS
TABLE 61 LIST OF KEY URINALYSIS PRODUCTS AVAILABLE
TABLE 62 URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 63 URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5.1 CLIPS & CARTRIDGES/PANELS
6.5.1.1 Clips and cartridges/panels to measure multiple electrolytes and metabolites kidney diseases and urinary tract infections detection
TABLE 64 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5.2 URINE ANALYZERS
6.5.2.1 Technological advancements to support market growth
TABLE 65 URINE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5.3 URINE TEST STRIPS
6.5.3.1 Urine test strips to qualitatively evaluate urine parameters
TABLE 66 URINE TEST STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 MOLECULAR DIAGNOSTICS
TABLE 67 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 68 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6.1 POLYMERASE CHAIN REACTION TESTS
6.6.1.1 Increased laboratory usage of PCR in proteomics and genomics to support market growth
TABLE 69 LIST OF POLYMERASE CHAIN REACTION TESTS AVAILABLE
TABLE 70 PCR TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6.2 MICROARRAYS
6.6.2.1 Growing applications of biochips in infectious diseases identification to propel market growth
TABLE 71 LIST OF MICROARRAYS TESTS AVAILABLE
TABLE 72 MICROARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 73 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES
TABLE 74 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 75 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CLINICAL PATHOLOGY
7.2.1 INCREASING PET HEALTH SCREENING AND DISEASE DIAGNOSIS TO MAKE CLINICAL PATHOLOGY LARGEST APPLICATION SEGMENT
TABLE 76 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 BACTERIOLOGY
7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH
TABLE 77 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 VIROLOGY
7.4.1 RISING NUMBER OF VIRAL OUTBREAKS TO SUPPORT MARKET GROWTH
TABLE 78 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 PARASITOLOGY
7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT MARKET GROWTH
TABLE 79 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 80 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE
8.1 INTRODUCTION
TABLE 81 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
8.2 DOGS
8.2.1 RISING PET DOG POPULATION TO DRIVE MARKET GROWTH
TABLE 82 DOG POPULATION, BY COUNTRY, 2018–2020 (MILLION)
TABLE 83 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CATS
8.3.1 GROWING RESEARCH INTO FELINE HEALTHCARE AND WELLBEING TO SUPPORT MARKET GROWTH
TABLE 84 CAT POPULATION, BY COUNTRY, 2018-2020 (MILLION)
TABLE 85 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 HORSES
8.4.1 GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH
TABLE 86 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER COMPANION ANIMALS
TABLE 87 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)
9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 88 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 DIAGNOSTIC LABORATORIES
9.2.1 DIAGNOSTIC LABORATORIES TO RECEIVE LARGE SAMPLE VOLUME FOR DIAGNOSIS
TABLE 89 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 VETERINARY HOSPITALS & CLINICS
9.3.1 VETERINARY HOSPITALS & CLINICS TO BE FIRST POINTS OF CONTACT FOR PET OWNERS
TABLE 90 BASIC ANNUAL EXPENSES FOR CATS AND DOGS IN THE US IN
2021-2022 (USD)
TABLE 91 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 RESEARCH INSTITUTES & UNIVERSITIES
9.4.1 INCREASING INDUSTRY-ACADEMIA COLLABORATIONS TO PROPEL MARKET GROWTH
TABLE 92 COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 HOME-CARE SETTINGS
9.5.1 IMPROVED CARE AND COST CONTROL TO DRIVE POC DIAGNOSTICS ADOPTION IN HOME CARE SETTINGS
TABLE 93 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME-CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 94 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
TABLE 95 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 96 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 97 NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 102 NORTH AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 103 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 104 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 105 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 107 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 108 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate companion animal diagnostics market in
North America
TABLE 109 US: PRIVATE CLINICAL PRACTICES FOR COMPANION ANIMAL, 2016 VS. 2020
FIGURE 35 US: EXPENDITURE ON VET VISITS
TABLE 110 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 111 US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 112 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 113 US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 116 US: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 US: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 118 US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 119 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 120 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 121 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 122 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Awareness of pet health to propel market growth
TABLE 123 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 124 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 125 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 126 CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 128 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 129 CANADA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 130 CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 131 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 132 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 133 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 134 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 135 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
FIGURE 36 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
TABLE 136 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 137 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 138 EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 139 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 140 EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 143 EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 144 EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 145 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 146 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 147 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 148 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 149 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany to dominate European companion animal diagnostics market
TABLE 150 GERMANY: PET POPULATION (CATS AND DOGS), 2017 VS. 2020 (MILLION)
TABLE 151 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 152 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 153 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 154 GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 156 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 157 GERMANY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 158 GERMANY: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 159 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 160 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 161 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 162 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 163 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Stable increase in pet ownership and preventive measures against animal diseases to drive market growth
TABLE 164 UK: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION)
TABLE 165 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 166 UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 167 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 168 UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 170 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 171 UK: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 172 UK: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 173 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 174 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 175 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 176 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 177 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Technological expertise and innovations to attract market players
TABLE 178 FRANCE: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION)
TABLE 179 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 180 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 181 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 182 FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 184 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 185 FRANCE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 186 FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 187 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 189 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 190 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 191 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increased pet adoption and better availability of pet products through large-scale outlets to support market growth
TABLE 192 ITALY: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION)
TABLE 193 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 194 ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 195 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 196 ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 198 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 199 ITALY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 200 ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 201 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 202 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 203 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 204 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 205 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising animal health expenditure and growing number of veterinary facilities to drive market growth
TABLE 206 SPAIN: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION)
TABLE 207 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 208 SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 209 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 210 SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 212 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 213 SPAIN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 214 SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 215 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 216 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 217 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 218 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 219 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 BENELUX
10.3.6.1 Increasing pet population in Benelux to drive market growth
TABLE 220 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 221 BENELUX: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 222 BENELUX: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 223 BENELUX: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 224 BENELUX: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 225 BENELUX: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 226 BENELUX: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 227 BENELUX: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 228 BENELUX: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 229 BENELUX: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 230 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 231 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 232 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 233 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 234 ROE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 235 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 236 ROE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 237 ROE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 238 ROE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 239 ROE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 240 ROE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 241 ROE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 242 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 243 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 244 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 245 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 37 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
TABLE 246 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 247 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 248 ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 249 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 250 ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 251 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 252 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 253 ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 254 ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 255 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 256 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 257 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 258 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 259 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China to dominate Asia Pacific companion animal diagnostics market
TABLE 260 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 261 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 262 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 263 CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 264 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 265 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 266 CHINA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 267 CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 268 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 269 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 270 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 271 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 272 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising demand for imported pet breeds to drive market growth
TABLE 273 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 274 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 275 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 276 JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 277 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 278 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 279 JAPAN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 280 JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 281 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 282 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 283 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 284 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 285 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Untapped market with large growth potential in companion animal diagnostics to support segment growth
TABLE 286 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 287 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 288 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 289 INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 290 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 291 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 292 INDIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 293 INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 294 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 295 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 296 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 297 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 298 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Rising pet insurance and pet health expenditure to drive market growth
TABLE 299 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 300 AUSTRALIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 301 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 302 AUSTRALIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 303 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 304 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 305 AUSTRALIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 306 AUSTRALIA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 307 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 308 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 309 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 310 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 311 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 312 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 313 REST OF ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 314 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 315 REST OF ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 316 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 317 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 318 REST OF ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 319 REST OF ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 325 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 326 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 327 LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 328 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 329 LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 330 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 331 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 332 LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 333 LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 334 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 335 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 336 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 337 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 338 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Brazil to possess third-largest pet population globally
TABLE 339 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 340 BRAZIL: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 341 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 342 BRAZIL: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 343 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 344 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 345 BRAZIL: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 346 BRAZIL: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 347 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 348 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 349 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 350 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 351 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Mexico to hold second-highest position in Latin American pet care market
TABLE 352 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 353 MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 354 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 355 MEXICO: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 356 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 357 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 358 MEXICO: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 359 MEXICO: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 360 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 361 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 362 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 363 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 364 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 365 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 366 REST OF LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 367 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 368 REST OF LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 369 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 370 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 371 REST OF LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 372 REST OF LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 373 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 374 REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 375 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 376 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 377 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST
10.6.1 RELUCTANCE TO SPEND ON PET HEALTH TO HINDER MARKET GROWTH
TABLE 378 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 379 MIDDLE EAST: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 380 MIDDLE EAST: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 381 MIDDLE EAST: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 382 MIDDLE EAST: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 383 MIDDLE EAST: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 384 MIDDLE EAST: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 385 MIDDLE EAST: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 386 MIDDLE EAST: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 387 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 388 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 389 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 390 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.7 AFRICA
10.7.1 DISEASES IN IMPORTED BREEDS TO DRIVE MARKET GROWTH
TABLE 391 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 392 AFRICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 393 AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 394 AFRICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 395 AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 396 AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 397 AFRICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 398 AFRICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 399 AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 400 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 401 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 402 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 403 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 38 REVENUE ANALYSIS OF TOP PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 39 COMPANION ANIMAL DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 40 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT (2021)
11.6 COMPANY EVALUATION QUADRANT FOR STARTUPS
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 STARTING BLOCKS
11.6.4 RESPONSIVE COMPANIES
FIGURE 41 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS (2021)
11.7 COMPANY PRODUCT FOOTPRINT
TABLE 404 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS
TABLE 405 ANIMAL TYPE FOOTPRINT OF MAJOR PLAYERS
TABLE 406 END USER FOOTPRINT OF MAJOR PLAYERS
TABLE 407 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS
11.8 COMPETITIVE SCENARIO
11.8.1 DEALS
TABLE 408 KEY DEALS, JANUARY 2019 TO MARCH 2022
11.8.2 PRODUCT LAUNCHES
11.8.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 IDEXX LABORATORIES, INC.
TABLE 409 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
12.1.2 ZOETIS INC.
TABLE 410 ZOETIS, INC.: BUSINESS OVERVIEW
FIGURE 43 ZOETIS, INC.: COMPANY SNAPSHOT
12.1.3 HESKA CORPORATION
TABLE 411 HESKA CORPORATION: BUSINESS OVERVIEW
FIGURE 44 HESKA CORPORATION: COMPANY SNAPSHOT
12.1.4 THERMO FISHER SCIENTIFIC INC.
TABLE 412 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
12.1.5 BIOM?RIEUX SA
TABLE 413 BIOM?RIEUX SA: BUSINESS OVERVIEW
FIGURE 46 BIOM?RIEUX SA: COMPANY SNAPSHOT
12.1.6 VIRBAC
TABLE 414 VIRBAC: BUSINESS OVERVIEW
FIGURE 47 VIRBAC: COMPANY SNAPSHOT
12.1.7 NEOGEN CORPORATION
TABLE 415 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 48 NEOGEN CORPORATION: COMPANY SNAPSHOT
12.1.8 FUJIFILM HOLDINGS CORPORATION
TABLE 416 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 49 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
12.1.9 INDICAL BIOSCIENCE GMBH
TABLE 417 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW
12.1.10 IDVET
TABLE 418 IDVET: BUSINESS OVERVIEW
12.1.11 RANDOX LABORATORIES, LTD.
TABLE 419 RANDOX LABORATORIES, LTD.: BUSINESS OVERVIEW
12.1.12 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
TABLE 420 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.:
BUSINESS OVERVIEW
12.1.13 BIONOTE, INC.
TABLE 421 BIONOTE, INC.: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 SKYLA CORPORATION
TABLE 422 SKYLA CORPORATION: BUSINESS OVERVIEW
12.2.2 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
TABLE 423 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.: BUSINESS OVERVIEW
12.2.3 URIT MEDICAL ELECTRONIC CO., LTD.
TABLE 424 URIT MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
12.2.4 EUROLYSER DIAGNOSTICA GMBH
TABLE 425 EUROLYSER DIAGNOSTICA GMBH: BUSINESS OVERVIEW
12.2.5 NOVA BIOMEDICAL
TABLE 426 NOVA BIOMEDICAL: BUSINESS OVERVIEW
12.2.6 FASSISI GMBH
TABLE 427 FASSISI GMBH: BUSINESS OVERVIEW
12.2.7 SWISSAVANS AG
TABLE 428 SWISSAVANS AG: BUSINESS OVERVIEW
12.2.8 ALVEDIA
TABLE 429 ALVEDIA: BUSINESS OVERVIEW
12.2.9 MEGACOR VETERINARY DIAGNOSTICS
TABLE 430 MEGACOR VETERINARY DIAGNOSTICS: BUSINESS OVERVIEW
12.2.10 BIOPANDA REAGENTS LTD
TABLE 431 BIOPANDA REAGENTS LTD: BUSINESS OVERVIEW
12.2.11 ANIPOC LTD
TABLE 432 ANIPOC LTD: BUSINESS OVERVIEW
12.2.12 RING BIOTECHNOLOGY CO LTD.
TABLE 433 RING BIOTECHNOLOGY CO LTD.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
